Edmund Graziani
Chief Executive Officer
Reata Pharmaceutical Inc.
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Edmund Graziani is the Chief Executive Officer at Apertor Pharmaceuticals, Inc., based in the United States. His research focuses on the development of novel therapeutic agents, as evidenced by his recent work on acyltransferase domain swap in modular type I polyketide synthase and site-specific antibody-drug conjugates for treating HER2-expressing cancers. Dr. Graziani's contributions aim to advance targeted cancer therapies and improve treatment outcomes.
Articles (2)
Year:
2022
Year:
2020
Collaborators (3)
Jay D. Keasling
University of California
UNITED STATES
L. Nathan Tumey
Binghamton University
UNITED STATES
Bo Pang
-
UNITED STATES
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.